Vanda Pharmaceuticals. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high...
What’s new on Vandapharmaceuticals.com: Check updates and related news right now. Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Vandapharmaceuticals.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
News, stories and media buzz related to Vanda Pharmaceuticals
-
Province: New South Wales Description: Find Jobs: Search thousands of jobs now | CareerOne.com.au Skip to Navigation Skip to job search form Skip to page content * Are You An Employer? If you’re looking to post a job or search resumes, go to http...
-
Financings of the Fortnight Isn’t Convinced You Have Nice Assetsvia
invivoblog.blogspot
Skeptical kitten wants to see what comes out the other side. Single-asset companies. Asset-centric funds. Project-based financing. Call it what you will, but with the biopharma news flow these days, you’d think the entire industry was restructuring...
-
September Spotlightvia
bioprocessintl
Women In Bio Launches Executive-Level Certification Program To prepare women in life sciences for roles on boards of directors, the national Women in Bio (WIB) organization has launched a program for executive-level board certification. “Women are significantly...
-
Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Mu...via
military-technologies
THOUSAND OAKS, Calif., May 31, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone...
-
Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking SessionPresentations Include Detailed Results From Across the Phase 3 AMAGINE Program Evaluating Brodalumab in More Than 4,200 Patients With...
You may also like
SOCRATES is an international, refereed (peer-reviewed) and indexed scholarly hybrid open-access journal in Public Administration a...
Pulmonary Hypertension | Janssen
Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal ...
Vandapharmaceuticals.com popular pages
-
Overview : About Vanda - VANDA Pharmaceuticals
Overview Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.
-
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
-
Product Pipeline - VANDA Pharmaceuticals
Tradipitant Tradipitant is being evaluated in a Phase II study in treatment resistant pruritus in atopic dermatitis. Tradipitant is an NK-1 receptor antagonist licensed from Eli Lilly in ...
Some worthy website to observe next
Website parameters
-
21 years
Domain age
-
N/A
Visit duration
-
N/A
Daily visitors
-
N/A
Bounce rate
